Barclays’s HI-TECH PHARMACAL INC HITK Stock Holding History

Barclays’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-483	Closed	-$21K	–	8082
2014 Q1	$21K	Sell	483 -1,454	-75%	-$63K	﹤0.01%	6595
2013 Q4	$83K	Sell	1,937 -5,989	-76%	-$259K	﹤0.01%	5811
2013 Q3	$341K	Sell	7,926 -71	-0.9%	-$2.72K	﹤0.01%	4515
2013 Q2	$266K	Buy	+7,997	New	+$266K	﹤0.01%	4902

Barclays's HITK Position: Q2 2014 in Review

Barclays sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 483 shares — an estimated $21K sold.

Barclays first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $341K in Q3 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

Barclays reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
Barclays sold 483 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $21K.
Barclays first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
Barclays's HI-TECH PHARMACAL INC position peaked at $341K in Q3 2013.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Barclays's 13F filing for Q2 2014, filed 14 Aug 2014.